Elanco Animal Health Incorporated (ELAN)
ELANNYSEBiotechnology: Pharmaceutical Preparations
$26.58
-0.1850 (-0.69%) today
Regular session, Nov 11, 9:48 AM ET
- Market cap
- $13.28bn
- P/E
- 23.3
- EPS, last 4 quarters
- $1.14
- Dividend yield
- –
- Day range
- $26.29 to $26.76
- 52-week range
- $19.40 to $27.98
- Average volume
- 4.54m
- Previous close
- $26.76
Analysts
12 coveringBuy10 buy, 2 hold, 0 sell
Targets a year out average $31.17, +17.3% from here
Earnings
next estimate $0.1700Next report
Dec 2025
+18.2%
Mar 2026
+17.6%
Jun 2026
+25.9%
Sep 2026
+35.0%
estimate reported, and the surprise
Financials
| Quarter | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| Revenue | $1.14bn | $1.37bn | $1.37bn | $1.26bn |
| Gross profit | $589.00m | $785.00m | $798.00m | $720.00m |
| Operating income | -$183.00m | $153.00m | $109.00m | $81.00m |
| Net income | -$276.00m | $57.00m | $54.00m | $18.00m |
Last four quarters: revenue $5.15bn, margin -2.9%, free cash flow $408.00m
News
8 latest- Elanco Animal Health: 3 Key Takeaways for Long-Term InvestorsThe Motley Fool · 2 days ago
- Elanco Animal Health Q3 Earnings Call HighlightsMarketBeat · 4 days ago
- Elanco (ELAN) Q3 2026 Earnings Call TranscriptThe Motley Fool · 5 days ago
- Elanco Animal Health Incorporated Reports Third Quarter 2026 Revenue of $1.265 billionFintel · 5 days ago
- Elanco Animal Health (ELAN) Reports Q3 Earnings: What Key Metrics Have to SayZacks · 5 days ago
- Elanco Q3 Swings To Profit, Revises Outlook; Pre-Market Shares Down RTTNews · 5 days ago
- Elanco Animal Health Incorporated (ELAN) Q3 Earnings and Revenues Surpass EstimatesZacks · 5 days ago
- U.S. Physical Therapy (USPH) Tops Q3 Earnings and Revenue EstimatesZacks · 7 days ago
The company
Elanco Animal Health Incorporated (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders and society as a whole. With more than 70 years of animal health heritage, we are committed to breaking boundaries and going beyond to help our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities. At Elanco, we are driven by our vision of Food and Companionship Enriching Life and our purpose - all to Go Beyond for Animals, Customers, Society and Our People.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Exchange
- NYSE
- Region
- North America
- Website
- elanco.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.